• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

5HT2A and 5HT2C receptor polymorphisms and predicting clinical response to olanzapine in schizophrenia.

作者信息

Ellingrod Vicki L, Perry Paul J, Lund Brian C, Bever-Stille Kristy, Fleming Frank, Holman Timothy L, Miller Del

出版信息

J Clin Psychopharmacol. 2002 Dec;22(6):622-4. doi: 10.1097/00004714-200212000-00014.

DOI:10.1097/00004714-200212000-00014
PMID:12454564
Abstract
摘要

相似文献

1
5HT2A and 5HT2C receptor polymorphisms and predicting clinical response to olanzapine in schizophrenia.
J Clin Psychopharmacol. 2002 Dec;22(6):622-4. doi: 10.1097/00004714-200212000-00014.
2
Effects of olanzapine plasma concentrations on depressive symptoms in schizophrenia: a pilot study.奥氮平血药浓度对精神分裂症患者抑郁症状的影响：一项初步研究。
J Clin Psychopharmacol. 2002 Oct;22(5):530-2. doi: 10.1097/00004714-200210000-00019.
3
5-HT2A receptor promoter polymorphism, -1438G/A and negative symptom response to olanzapine in schizophrenia.5-羟色胺2A受体启动子多态性，-1438G/A与精神分裂症患者对奥氮平的阴性症状反应
Psychopharmacol Bull. 2003 Spring;37(2):109-12.
4
Olanzapine: an updated review of its use in the management of schizophrenia.奥氮平：其在精神分裂症治疗中应用的最新综述
Drugs. 2001;61(1):111-61. doi: 10.2165/00003495-200161010-00011.
5
Olanzapine versus other antipsychotics in the treatment of schizophrenia.奥氮平与其他抗精神病药物治疗精神分裂症的比较。
J Clin Psychiatry. 2001 Oct;62(10):828-9. doi: 10.4088/jcp.v62n1012c.
6
5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation.奥氮平对精神分裂症患者5-HT2和D2受体的占有率：一项正电子发射断层扫描（PET）研究
Am J Psychiatry. 1998 Jul;155(7):921-8. doi: 10.1176/ajp.155.7.921.
7
Multiple genetic factors in olanzapine-induced weight gain in schizophrenia patients: a cohort study.精神分裂症患者中奥氮平所致体重增加的多种遗传因素：一项队列研究。
J Clin Psychiatry. 2008 Sep;69(9):1416-22. doi: 10.4088/jcp.v69n0909.
8
First clinical experience with olanzapine (LY 170053): results of an open-label safety and dose-ranging study in patients with schizophrenia.奥氮平（LY 170053）的首次临床经验：一项针对精神分裂症患者的开放标签安全性及剂量范围研究的结果
Int Clin Psychopharmacol. 1995 Nov;10(4):239-44.
9
Olanzapine plasma concentrations and clinical response in acutely ill schizophrenic patients.急性病精神分裂症患者的奥氮平血药浓度与临床反应
J Clin Psychopharmacol. 1997 Dec;17(6):472-7. doi: 10.1097/00004714-199712000-00006.
10
A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia.肌肉注射奥氮平与氟哌啶醇治疗精神分裂症急性激越的双盲、安慰剂对照剂量反应比较
Arch Gen Psychiatry. 2002 May;59(5):441-8. doi: 10.1001/archpsyc.59.5.441.

引用本文的文献

1
Efficacy of atypical antipsychotics in schizophrenia patients: effects of 5-HTR SNPs.非典型抗精神病药物对精神分裂症患者的疗效：5-羟色胺受体单核苷酸多态性的影响
Ann Gen Psychiatry. 2025 Feb 18;24(1):10. doi: 10.1186/s12991-025-00547-z.
2
Association between the rs6313 polymorphism in the 5-HTR2A gene and the efficacy of antipsychotic drugs.5-HTR2A 基因 rs6313 多态性与抗精神病药物疗效的关系。
BMC Psychiatry. 2023 Sep 19;23(1):682. doi: 10.1186/s12888-023-05165-1.
3
Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates.
难治性精神分裂症：遗传与神经影像学关联
Front Pharmacol. 2019 Apr 16;10:402. doi: 10.3389/fphar.2019.00402. eCollection 2019.
4
Pharmacogenetics of antipsychotics.抗精神病药物的药物遗传学。
Can J Psychiatry. 2014 Feb;59(2):76-88. doi: 10.1177/070674371405900203.
5
The impact of atypical antipsychotic use on obstructive sleep apnea: a pilot study and literature review.非典型抗精神病药物使用对阻塞性睡眠呼吸暂停的影响：一项初步研究和文献回顾。
Sleep Med. 2011 Jun;12(6):591-7. doi: 10.1016/j.sleep.2010.12.013.
6
Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction.药物遗传学与抗精神病药：疗效和副作用预测。
Expert Opin Drug Metab Toxicol. 2011 Jan;7(1):9-37. doi: 10.1517/17425255.2011.532787.
7
Effects of clozapine and 2,5-dimethoxy-4-methylamphetamine [DOM] on 5-HT2A receptor expression in discrete brain areas.氯氮平和2,5-二甲氧基-4-甲基苯丙胺[DOM]对离散脑区5-HT2A受体表达的影响。
Pharmacol Biochem Behav. 2005 Aug;81(4):750-7. doi: 10.1016/j.pbb.2005.05.011.
8
Intramuscular olanzapine: a review of its use in the management of acute agitation.肌内注射奥氮平：其在急性激越管理中的应用综述
CNS Drugs. 2005;19(2):147-64. doi: 10.2165/00023210-200519020-00005.
9
Pharmacogenetics and psychiatry.
Curr Psychiatry Rep. 2004 Apr;6(2):134-42. doi: 10.1007/s11920-004-0053-5.